Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a small platform update rather than changes to study information or layout.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6, indicating a minor backend revision.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, representing a minor update to the page's revision history. No changes to the study details or core content are indicated.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded NIH-required analyses for adverse events by sex and by race for mothers and infants, and updated timeframes (e.g., From birth through Week 50 postpartum) and measure descriptions to reflect these analyses.SummaryDifference1%

- Check53 days agoChange Detected- Page revision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or its documentation. This change does not alter the study content presented on the page.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.